Form 4 Tracker
CASTLE BIOSCIENCES INC
CSTL

60 insider filings · Latest: Oct 12, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Oct 12, 2026Oct 14 8:06 PMTobin W JuvenalChief Commercial Officer
Sale
3,288$33.64$110.6K48,719(D)

View →

Oct 12, 2026Oct 13 12:52 PMTobin Juvenal
Proposed Sale
13,154$32.76$430.9K—

View →

Oct 5, 2026Oct 7 8:10 PMDerek J MaetzoldDirector, Pres. & Chief Exec. Officer
Sale
14,496$35.57$515.6K6,832(I)

View →

Oct 5, 2026Oct 5 10:24 PMDerek Maetzold
Proposed Sale
28,992$36.65$1.1M—

View →

Oct 1, 2026Oct 5 8:07 PMKristen M OelschlagerChief Operating Officer
Sale
4,153$35.95$149.3K13,356(D)

View →

Oct 1, 2026Oct 1 8:24 PMKRISTEN OELSCHLAGER
Proposed Sale
4,153$35.53$147.6K—

View →

Sep 30, 2026Oct 1 8:21 PMTobin W JuvenalChief Commercial Officer
Sale
1,034$34.20$35.4K52,007(D)

View →

Sep 29, 2026Oct 1 8:21 PMTobin W JuvenalChief Commercial Officer
Sale
5,543$35.50$196.8K53,041(D)

View →

Sep 21, 2026Sep 23 8:27 PMDerek J MaetzoldDirector, Pres. & Chief Exec. Officer
Sale
14,496$35.33$512.2K9,550(I)

View →

Sep 15, 2026Sep 16 8:20 PMTobin W JuvenalChief Commercial Officer
Sale
3,294$35.14$115.8K58,584(D)

View →

Sep 14, 2026Sep 16 8:20 PMTobin W JuvenalChief Commercial Officer
Sale
3,306$32.32$106.9K61,878(D)

View →

Sep 11, 2026Sep 15 8:08 PMDerek J MaetzoldDirector, Pres. & Chief Exec. Officer
Sale
14,518$32.02$464.9K12,268(I)

View →

Sep 14, 2026Sep 14 10:00 PMTobin Juvenal
Proposed Sale
13,177$33.44$440.6K—

View →

Sep 11, 2026Sep 11 10:53 PMDerek Maetzold
Proposed Sale
29,014$32.33$938.0K—

View →

Sep 1, 2026Sep 3 8:07 PMKristen M OelschlagerChief Operating Officer
Sale
4,152$33.39$138.6K13,356(D)

View →

Aug 31, 2026Sep 2 8:07 PMTobin W JuvenalChief Commercial Officer
Sale
1,730$32.81$56.8K65,184(D)

View →

Aug 28, 2026Sep 1 8:12 PMDerek J MaetzoldDirector, Pres. & Chief Exec. Officer
Sale
18,560$33.20$616.1K11,256(I)

View →

Aug 25, 2026Aug 27 8:38 PMTobin W JuvenalChief Commercial Officer
Sale
9,050$35.04$317.1K66,914(D)

View →

Aug 25, 2026Aug 26 8:16 PMKristen M OelschlagerChief Operating Officer
Sale
12,384$34.42$426.3K72,649(I)

View →

Aug 24, 2026Aug 26 8:16 PMKristen M OelschlagerChief Operating Officer
Sale
12,218$33.69$411.6K85,033(I)

View →

Page 1 of 6

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 4, 2026Mar 5 10:18 PMTobin W JuvenalChief Commercial Officer
Option Exercise
25,771—35,878(D)

View →

Mar 3, 2026Mar 5 10:18 PMTobin W JuvenalChief Commercial Officer
Grant/Award
48,367—48,367(D)

View →

Mar 4, 2026Mar 5 10:16 PMKristen M OelschlagerChief Operating Officer
Option Exercise
25,771—35,878(D)

View →

Mar 3, 2026Mar 5 10:16 PMKristen M OelschlagerChief Operating Officer
Grant/Award
48,367—48,367(D)

View →

Mar 4, 2026Mar 5 10:12 PMDerek J MaetzoldDirector, Pres. & Chief Exec. Officer
Option Exercise
59,097—83,961(D)

View →

Mar 3, 2026Mar 5 10:12 PMDerek J MaetzoldDirector, Pres. & Chief Exec. Officer
Grant/Award
102,597—102,597(D)

View →

Mar 4, 2026Mar 5 10:08 PMFrank StokesChief Financial Officer
Option Exercise
27,946$3.3814,912(D)

View →

Mar 3, 2026Mar 5 10:08 PMFrank StokesChief Financial Officer
Grant/Award
48,367—48,367(D)

View →

← Previous

Page 3 of 3